Duke University’s Athletic Training Division Acquires Five BiowavePRO® Pain Therapy Systems
January 31, 2011
Biowave Corporation is pleased to announce that Duke University’s Athletic Training Division
has purchased five BiowavePRO Neuromodulation Pain Therapy Systems for use by their certified athletic trainers in their various
n campus athletic training facilities and treating athletes on the road. This decision was reached after an extensive evaluation of
BiowavePRO across all of Duke Athletics’ Men’s and Women’s sports.
Jose Fonseca, Head Athletic Trainer for Duke Men’s Basketball, recognized BiowavePRO as a significant tool when he utilized it in treating the Men’s Basketball team during their exciting run in winning the 2010 NCAA Men’s National Championship Basketball Tournament. Mr. Fonesca commented, “We find that when our athletes are treated with BiowavePRO they report better pain relief and functional improvement than with other electrical stimulation modalities. They choose to be treated with the 'Blue Box'© when entering the training room.”
In making the BiowavePRO purchase decision, Hap Zarzour, Director of Athletic Training, commented, “We found the BiowavePRO systems were easy to use, very portable, the treatment was controlled by the athlete freeing our trainers to attend to other athletes and the economics of use are positive.”
BiowavePRO is an electronic neuromodulation pain therapy system that blocks pain non-invasively, enables a greater range of motion and is designed for use in sports, athletic training, physical and occupational therapy and pain clinic settings.
Duke University’s Athletic Training Division’s 16 certified athletic trainers provide physical rehabilitation and therapy services to 625 student-athletes across 26 highly competitive varsity intercollegiate teams.
Biowave Corporation, a medical device company based in Norwalk, CT, manufactures two FDA approved prescription neuromodulation pain therapy systems, BiowavePRO and Homewave® which utilize a unique proprietary signal mixing technology to deliver electrical signals through the skin into deep tissue for inhibiting pain transmission and enabling a greater range of motion. The signal technology is covered by four issued US patents.
Copyright 2011 Biowave Corporation